Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
HQ United Kingdom · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products not yet catalogued.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
No adverse media involving Proximie found in HSH's search of the last 24 months.
No data breaches, cyber incidents or regulator action involving Proximie found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
No recalls, safety notices or clinical safety actions involving Proximie found in HSH's search of the last 24 months.
Apr 2026: Proximie announced a collaboration with NVIDIA on AI for intelligent operating rooms. No notable NHS contract awards, disputes or troubled implementations involving Proximie found in HSH's search of the last 24 months.
No competitors linked yet.